Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
34 results about "Time to hemostasis" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Hemostasis is a process which takes three to six minutes in normal individuals. Disorders of hemostasis are researched by studying the different time the hemostasis process takes, from the bleeding time, the activated partial thromboplastin time, and the prothrombin time.
Medical hemostatic polysaccharide starch microsphere and preparation method thereof
ActiveCN104311870AAbsorb quickly and completelyDisorganized reactionOrganic active ingredientsPotato starchStarch Microspheres
The invention relates to a preparation method and a refining method of medical hemostatic polysaccharide starch. With pretreated potato starch as a raw material and epichlorohydrin as a crosslinking agent, a microsphere adopting a three-dimensional network structure is synthesized by an emulsifying and crosslinking technology. The medical hemostatic polysaccharide starch is high in biocompatibility; the medical hemostatic polysaccharide starch is full with wrinkles on the surface, so that the particle surface area is increased, the water absorbing rate is significantly improved and the hemostatic time is greatly reduced; the medical hemostatic polysaccharide starch is especially applicable to large-area blood seepage, deep bleeding, and bleeding at a part difficult to reach by operative procedures.
Owner:SHIJIAZHUANG YISHENGTANG MEDICAL SUPPLIES
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site. The method further comprises administering an anticoagulant to a patient at a dose ranging from about 20 units per kg of body weight to about 30 units per kg of body weight.
Owner:VASOINNOVATIONS
Alkyl chitosan-graphene oxide composite sponge and preparation method and application thereof
ActiveCN109966544APromote absorptionShorten hemostasis timeSurgical adhesivesPharmaceutical delivery mechanismOxide compositeFemoral artery
The invention belongs to the technical field of medical materials, and particularly relates to alkyl chitosan-graphene oxide composite sponge and a preparation method and application thereof. The composite sponge comprises alkyl chitosan and graphene oxide adsorbed on alkyl chitosan, and adsorption capacity of graphene oxide is 3-28%. The composite sponge obtained by taking alkyl chitosan as a matrix and compositing graphene oxide and alkyl chitosan has excellent hemostatic performance and blood absorbing capacity. Embodiment results show that when the composite sponge is used for hemostasis,in-vitro whole blood coagulation time is less than 58s, hemostasis time of a rabbit femoral artery bleeding model is less than 155s, bleeding amount is less than 5.4g, and hemostasis effect is betterthan pure alkyl chitosan sponge or graphene oxide powder.
Owner:INST OF MEDICAL SUPPORT TECH OF ACAD OF SYST ENG OF ACAD OF MILITARY SCI
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site. The method further comprises administering an anticoagulant to a patient at a dose ranging from about 20 units per kg of body weight to about 30 units per kg of body weight.
Owner:VASOINNOVATIONS
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site.
Owner:VASOINNOVATIONS
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site. The method further comprises administering an anticoagulant to a patient at a dose ranging from about 20 units per kg of body weight to about 30 units per kg of body weight.
Owner:VASOINNOVATIONS
Hemostatic material based on combination of chitosan and tissue factor, and preparation method thereof
ActiveCN111729126ARapid hemostasisStable and fast hemostasisSurgical adhesivesAbsorbent padsTissue factorEmulsion
A hemostatic material based on combination of chitosan and a tissue factor, and a preparation method thereof aim to realize short hemostasis time and good hemostasis effects. The hemostatic materialsare mainly prepared from the following components of a formula in parts by mass: 100 parts of the chitosan, 0.1-0.2 milli part of the human recombinant tissue factor, 0.04-0.06 part of phospholipid, 0.1-0.2 part of trehalose and 0.04-0.08 part of CaCl2. The preparation method comprises: preparing an emulsion by high-pressure treatment of the human recombinant tissue factor and the phospholipid, and then preparing a mixture of carboxymethyl chitosan and the human recombinant factor in ways of adding 0.02 ml of the emulsion in each gram of the carboxymethyl chitosan; performing vacuum freezing and drying after pre-freezing of 5-10 h at -40 to -80 DEG C; and grinding and sieving the mixture by a 100-mesh sieve into powder at an environmental temperature of 15-20 DEG C and the humidity of 30%,so as to obtain the external-use quick hemostatic material.
Owner:BEIJING REDCUBE MEDICAL EQUIP +1
Blood vessel ligation device with repeating function
InactiveCN111544076AQuick ligationEffective ligationWound clampsMinimal invasive surgeryExcessive Bleeding
The invention discloses a blood vessel ligation device with a repeating function. The device comprises a gun body, a ligature clamp storage device, an excitation device, a ligature clamp and a fixingclamp, wherein the ligature clamp storage device is arranged on the left side of the gun body; the excitation device is arranged in the gun body; the ligature clamp is stored in the ligature clamp storage device; the ligature clamp is excited by the excitation device; and the fixing clamp is arranged on the gun body. When bleeding is excessive and bleeding points are not easy to find, the goal ofrepeatedly, quickly and effectively ligating blood vessels and tissues can be achieved, hemostasis time is shortened, operative efficiency is improved, success rate of operation is increased, and lifesafety of a patient is maintained. In addition, hemostasis can be achieved quickly in minimally invasive surgery, the intuition of excessive bleeding under the visual angle of an endoscope is avoidedfor surgeons, psychological mood of surgeons is prevented from being affected, and adverse consequences to a surgery are avoided.
Owner:JILIN UNIV FIRST HOSPITAL
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site.
Owner:VASOINNOVATIONS
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site. The method further comprises administering an anticoagulant to a patient at a dose ranging from about 20 units per kg of body weight to about 30 units per kg of body weight.
Owner:VASOINNOVATIONS
Uses of cyclic adenosine monophosphate or derivatives thereof in omental hemorrhage after surgical operation
ActiveCN105343119AEnhance anti-bleeding abilityAvoid damageOrganic active ingredientsDigestive systemSurgical operationHuman body
The invention relates to uses of cyclic adenosine monophosphate or derivatives thereof, and specifically relates to uses of cyclic adenosine monophosphate or derivatives thereof in omental hemorrhage after surgical operation. Low dosage of cyclic adenosine monophosphate or derivatives can effectively reduce amount and area of omental hemorrhage after surgical operation, reduce hemostasis time of omental hemorrhage after surgical operation, and relieve the damage degree of human body.
Owner:SHANGHAI JINCHENG PHARMACEUTICAL CO LTD
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site. The method further comprises administering an anticoagulant to a patient at a dose ranging from about 20 units per kg of body weight to about 30 units per kg of body weight.
Owner:VASOINNOVATIONS
Inner pile treating orally taken medicine
InactiveCN1772063ALow costRapid hemostasisCapsule deliveryDermatological disorderFormularyEngineering
The present invention discloses one kind of inner pile treating orally taken medicine. The medicine is prepared with date and sulphur as material in certain weight ratio and through unique preparation process based on the different characteristics of the medicine materials. The medicine has the advantages of fast acting, fast hemostasis, fast healing and no recurrence.
Owner:夏志刚
Hemostatic plugging compression device
InactiveCN110559040AMonitor hemostasis timeGood hemostatic effectMedical applicatorsTourniquetsMuscle tissueTourniquet time
The invention provides a hemostasis plugging compression device. The hemostasis plugging compression device is used for monitoring the pressure condition between a compression air bag and a shell, thepressure condition between the skin of the patient and a compressor is indirectly reflected, an alarm can be given in time while detecting that the pressure is too large or the compression time is too long, medical staff can come for treatment in time, and great convenience is brought to the patient and the medical staff; the hemostasis time of a tourniquet on the wound surface and the pressure of the tourniquet on the wound surface can be monitored, the tourniquet is automatically inflated or deflated according to an air pressure value in the tourniquet and the hemostasis time to adjust thepressure of the tourniquet on the wound surface so as to improve the hemostasis effect on the wound surface, and therefore the situation that muscle tissue on the wound surface necrotizes due to the fact that the tourniquet continuously presses blood vessels on the wound surface for a long time can be avoided.
Owner:慈溪市人民医院
Method for preparing absorbable haemostatic composition for body and haemostatic composition prepared thereby
ActiveUS20220176009A1Effective hemostasisAccelerates hemostasis speedSurgical adhesivesPharmaceutical delivery mechanismSurgical operationTissue repair
The present disclosure relates to a method for preparing an absorbable haemostatic composition for the body and the haemostatic composition prepared thereby, and the present disclosure is for providing a method for preparing an absorbable haemostatic composition for the body and the haemostatic composition prepared thereby, wherein the haemostatic composition can be used directly on the wound site when bleeding occurs in the surgical area such as surgical operation, trauma, etc. so that hemostasis can be effectively performed, the haemostatic composition can perform wound sealing, tissue repairing promotion, wound surface tissue protection, infection prevention, etc., the haemostatic composition is contained in haemostatic products such as gauze (cotton yarn), sponge, etc. to accelerate the hemostasis speed of the bleeding site and enable rapid hemostasis to be able to shorten the hemostasis time at the same time.
Owner:MANTIZ LOGITECH CO LTD
Hemostatic material leading-in device
PendingCN113521516ASelf-rescue is fast and efficientEasy to operateMedical devicesEngineeringTime to hemostasis
The invention discloses a hemostatic material leading-in device. Thehemostatic material leading-in device comprises a barrel transited to a cylinder in a streamline mode, the discharging end of the barrel is composed of a plurality of petal bodies, an inner cavity of the barrel is a hemostatic material containing space, the hemostatic material leading-in device is characterized in that a piston is arranged at the rear end of the barrel, the outer diameter of the piston is consistent with the inner diameter of the barrel, and the piston and the barrel can slide relative to each other in a matched mode; an inner hole is formed in the middle of the piston, a push rod arranged in the cylinder penetrates through the inner hole in the middle of the piston, and the push rod penetrates through the inner hole of the piston and can slide relatively. An elastic piece clamped with the push rod in a matched mode is arranged in an inner hole of the piston. The medicine carrying barrel and the piston push rod are integrally designed, the barrel and the push rod do not need to be assembled during use, only the push rod needs to be pulled out of the barrel, one-hand operation can be achieved, operation is convenient and fast, the hemostasis time is shortened, self rescue of a wounded person is faster and more efficient, and the rescue success rate is effectively increased.
Owner:青岛博益特生物材料股份有限公司
Low-cost antimicrobial and hemostasis ointment and preparation method thereof
InactiveCN105999390AShort hemostatic timeReduce bleedingPharmaceutical delivery mechanismBandagesVitamin E AcetateWater soluble polysaccharides
The invention discloses a low-cost antimicrobial and hemostasis ointment and a preparation method thereof. The hemostasis ointment is prepared from, by weight 40-60 parts of cafboxymethyl chitosan, 11-18 parts of corn starch, 7-15 parts of aminated dextran, 4-10 parts of potassium alginate, 4-12 parts of earthworm dry powder, 4-9 parts of molecular sieves, 8-16 parts of water-soluble polysaccharide, 14-30 parts of tricalcium phosphate, 8-15 parts of vitamin E acetate, 7-12 parts of lanthanum phosphate, 12-27 parts of glycerinum and 62-90 parts of double distilled water. The hemostasis ointment is short in hemostasis time and small in bleeding amount, the antimicrobial rate is larger than 98.7%, the good hemostasis effect and the good antimicrobial performance in the preliminary stage of a wound are shown, the biological compatibility is good, and the hemostasis ointment is convenient to carry and has the good application prospect.
Owner:王泽陆
A kind of micro/nano hierarchical porous microsphere and its preparation method and application
ActiveCN112535759BAvoid enteringNot easy to slipSurgical adhesivesPharmaceutical delivery mechanismVascular tissueRed blood cell
Owner:JINAN UNIVERSITY
A starch-based microporous hemostatic material with antibacterial properties and its preparation method and application
ActiveCN107412843BLarge specific surface areaStrong water absorptionPharmaceutical delivery mechanismAbsorbent padsWound siteBiocompatibility
The invention discloses a starch-based microporous hemostatic material with antibacterial properties, a preparation method and application thereof. The present invention first prepares starch-based microporous starch, and then loads amino ions, thereby finally preparing a pore size of 0.1-6 μm, a hemostasis time of 20s-4min, a bactericidal rate of 50%-100%, and 4h-10d that can be completely degraded in vivo Positively charged starch-based microporous hemostatic material. The material can quickly and effectively stop bleeding and also has antibacterial function, which can prevent infection of the wound site and accelerate wound healing, but has no damage to normal cells. The present invention adopts starch with wide sources and low price as raw material, and loads amino groups after microporation, thus preparing a hemostatic material with physical and chemical hemostatic mechanism, which has fast hemostatic speed, high viscosity and good biocompatibility. It degrades quickly in the body, has a wide range of applications, and has dual functions of hemostasis and antibacterial.
Owner:苏州佰济生物科技有限公司
Clinical hemostasis rescue equipment for internal medicine department
InactiveCN113499114AEasy to installAdjust squeeze strengthSurgeryTime to hemostasisBiomedical engineering
The invention discloses clinical hemostasis rescue equipment for the internal medicine department. The equipment comprises a main body structure, an extrusion structure and an auxiliary structure, wherein the extrusion structure is detachably arranged on the main body structure, and the auxiliary structure is detachably arranged on the extrusion structure. The invention relates to the technical field of medical instruments. According to the equipment, through cooperation of the main body structure and the extrusion structure, the equipment can be conveniently installed on the limbs of a patient, a rubber band can be pulled by moving a lock frame, the extrusion force can be adjusted, meanwhile, the distance between an extrusion plate and a main body plate can be relatively adjusted, and the equipment can be used according to different thicknesses of the limbs of the patient; the auxiliary structure can be installed to carry out extrusion hemostasis on other wounds. The equipment is convenient and fast to install and convenient to carry, can be adjusted according to the thickness of limbs of a patient, can also adjust the extrusion force to achieve effective hemostasis, and saves hemostasis time.
Owner:滨州市滨城区滨北街道办事处社区卫生服务中心
Micro/nano hierarchical porous microspheres as well as preparation method and application thereof
ActiveCN112535759AAvoid enteringNot easy to slipSurgical adhesivesPharmaceutical delivery mechanismVascular tissueRed blood cell
The invention discloses micro / nano hierarchical porous microspheres as well as a preparation method and application thereof. The preparation method comprises the following steps of (1) preparing a mixed solution of chitin nanofibers and chitosan; (2) preparing a Pickering emulsion; and (3) preparing the micro / nano hierarchical porous microspheres. The preparation method is simple, mild in reactioncondition and low in cost; red blood cells and blood platelets are prevented from entering the microspheres by controlling the pore sizes of the outer surfaces of the prepared microspheres, so that the wound hemostasis time is shortened and wound repair is promoted; the pore walls of the microspheres are connected by chitin nanofibers, so that collagen fiber forms in subcutaneous matrixes in vascular tissues can be simulated; the blood platelets are adhered and activated, so that the acceleration of hemostasis is facilitated, wound surface blood is effectively adsorbed, and the wound surfaceis kept dry; and when the chitosan is in contact with blood, the structure of polycations of the chitosan and the binding force between molecules of the chitosan and cell membranes enable whole bloodto be coagulated, so that the hemostatic process is accelerated, wound infection is inhibited, and cell proliferation is promoted.
Owner:JINAN UNIVERSITY
A kind of preparation method of novel medical hemostatic gel dressing
ActiveCN107349464BHas antibacterial propertiesImprove breathabilitySurgical adhesivesPharmaceutical delivery mechanismProtein solutionTime to hemostasis
The invention relates to a method for preparing a medical hemostatic gel dressing. Human-like collagen (LHC) is dissolved in ultrapure water to prepare a protein solution, and inorganic salts and complex cross-linking agents β-diimine zinc complex and 1,2,7,8-Diepoxyoctane, adjust the pH value of the solution to 2-5.5, stir evenly and place the mixed solution in a 40-80°C water bath for 0.5-5h, and then undergo two high-temperature steam treatments in sequence After washing with water, drying and Co-60 irradiation sterilization, a new type of sterile medical hemostatic gel dressing can be obtained. The medical hemostatic gel dressing prepared by the invention has good air permeability and antibacterial properties, will not cause wound infection, and can significantly shorten the hemostasis time. The hemostatic material will not adhere to the wound after hemostasis is completed, which significantly reduces the patient's pain.
Owner:NORTHWEST UNIV
A medical glue with high-efficiency anti-inflammatory and hemostatic functions
ActiveCN108888801BInhibition of exudationPrevent edemaSurgical adhesivesPharmaceutical delivery mechanismIsooctyl acrylateOctyl cyanoacrylate
The invention discloses a medical adhesive with efficient anti-inflammation and hemostasis functions. The medical adhesive is characterized by comprising, by weight, 20-25 parts of alpha-N-octyl cyanoacrylate, 25-35 parts of alpha-isooctyl cyanoacrylate, 2-6 parts of polyvinyl acetate, 12-20 parts of efficient anti-inflammation components, 13-23 parts of efficient hemostasis components, 3-6 partsof cell activators MG-60, 8-10 parts of allantoin, 1 part of hydrolyzed wheat protein, 1 part of stabilizers, 150-220 parts of compound anti-inflammatory fruit oil components and 200 parts of sterilewater. The medical adhesive particularly selects various extracts with the anti-inflammation and hemostasis functions, two efficient anti-inflammation components and one efficient hemostasis componentare added, so that overall anti-inflammation and hemostasis effects are improved, and the medical adhesive is high in bonding strength and short in hemostasis time and meets application requirementsof clinical medical adhesives.
Owner:浙江派菲特新材料科技有限公司
A kind of preparation method of hemostatic gel dressing containing zeolite
ActiveCN107261199BSolve residual problemsShorten hemostasis timePharmaceutical delivery mechanismBandagesInorganic saltsCollagenan
The invention relates to a method for preparing a porous hemostatic gel dressing based on human-like collagen and zeolite. The mass ratio of zeolite to human-like collagen is 1:10-1:20, adding an appropriate amount of zeolite to the LHC solution, adding inorganic salts and Stir the complex cross-linking agent β-diimine zinc complex and 1,2,7,8-diepoxyoctane evenly, adjust the pH value of the solution to acidic conditions, and place it in a 40-80°C water bath to maintain 0.5- After 5 hours, high-temperature steam treatment and water washing are repeated twice to remove salt and cross-linking agent residues. After drying and Co-60 sterilization, a zeolite-containing hemostatic gel dressing can be obtained. In addition to the good breathability, anti-adhesion and rapid hemostatic effect of this material, the gel medium itself disperses the zeolite particles, which greatly alleviates the exothermic problem caused by the zeolite during the hemostatic effect. Compared with the situation without introducing zeolite gel, the hemostasis time is significantly shortened to 15-25s on average.
Owner:NORTHWEST UNIV
A kind of absorbable rapid hemostasis material and preparation method thereof
ActiveCN106540310BGood biocompatibilityGood biodegradableSurgical adhesivesMicrocapsulesCelluloseOyster shells
The invention discloses an absorbable rapid bleeding stopping material and a preparation method thereof. The material comprises medicine carrying calcium alginate porous microspheres, oyster shell powder and sodium carboxymethylcellulose. The medicine carrying calcium alginate porous microspheres and the oyster shell powder have the following two functions: firstly, the medicine carrying calcium alginate porous microspheres and the oyster shell powder serve as a molecular sieve, and can rapidly absorb the water in blood when making contact with the blood, so that visible components in the blood can be rapidly concentrated; secondly, the medicine carrying calcium alginate porous microspheres and the oyster shell powder can release a large number of calcium ions for acting on blood coagulation factors which are concentrated on the material surface, blood coagulation is accelerated, bleeding stopping time is shortened, and the amount of bleeding is reduced. The adopted materials are natural macromolecule polysaccharide and inorganic salt, and the characteristics of good biocompatibility, biodegradability, safety, non-toxicity, absorbability, bleeding stopping ability and the like are achieved. The preparation process is simple, the medicine can be released continuously and steadily within a certain period of time, and the absorbable rapid bleeding stopping material can bring great benefits to the medical field and the society.
Owner:JINAN UNIVERSITY
A kind of fluid hemostatic glue and preparation method thereof
ActiveCN111375085BAccelerate solidificationPromotes compression hemostasisSurgical adhesivesPharmaceutical delivery mechanismWound healingTime to hemostasis
The invention provides a fluid hemostatic glue and a preparation method thereof. The fluid hemostatic glue comprises cross-linked chitosan or a derivative thereof, cross-linked water-soluble protein or polypeptide, and a lubricant. The hemostatic glue according to the present invention does not contain coagulation factors, is in the form of a flowable ointment, has a suitable swelling degree, can be used directly without any time-consuming reconstruction steps, has short hemostasis time, fast wound healing, and is easy to use. Fast, degradable in vivo, and good biocompatibility.
Owner:IMEIK TECH DEV CO LTD
A kind of hemostatic material based on the combination of chitosan and tissue factor and its preparation method
ActiveCN111729126BRapid hemostasisStable and fast hemostasisSurgical adhesivesAbsorbent padsTissue factorEmulsion
A hemostatic material based on a combination of chitosan and tissue factor and a preparation method thereof, aiming at short hemostatic time and good hemostatic effect; the main components of the hemostatic material and their formula in parts by mass are: 100 parts of chitosan, human Recombinant tissue factor 0.1-0.2 milliparts, phospholipids 0.04-0.06 parts, trehalose 0.1-0.2 parts, CaCl 2 0.04-0.08 part; the preparation method is to prepare human recombinant tissue factor and phospholipids into an emulsion under high pressure, and then add 0.02 ml of emulsion per gram of carboxymethyl chitosan to prepare carboxymethyl chitosan and human recombinant tissue Factor mixture; pre-freeze at -40°C to -80°C for 5-10 hours and then vacuum freeze-dry; at an ambient temperature of 15-20°C and a humidity of 30%, grind it through a 100-mesh sieve into powder for external use Rapid hemostasis material.
Owner:BEIJING REDCUBE MEDICAL EQUIP +1
Absorbable hemostatic dressing
PendingCN114848886APromote absorptionInhibit swellingSurgical adhesivesPharmaceutical delivery mechanismTraditional medicineTime to hemostasis
The invention discloses an absorbable hemostatic dressing. Comprising the following raw material components in parts by weight: 50-100 parts of hydroxyethyl chitin, 30-80 parts of ossein, 3-10 parts of eel blood extract and 3-10 parts of longflower stringbush root extract. The prepared hemostatic dressing is good in absorbability, wound swelling and infection can be effectively avoided after hemostasis, and few scars are left after healing; the combined use of the eel blood extract and the longflower stringbush root extract prolongs the hemostasis time, and the combined use has a synergistic effect.
Owner:扬州卓和医用材料有限公司
A tourniquet with automatic pressure release at regular intervals
ActiveCN109498100BEasy to operateGuaranteed hemostasis timeTourniquetsControl cellEmergency medicine
The invention belongs to the field of medical auxiliary instruments, and relates to a tourniquet capable of depressurizing automatically and regularly. The tourniquet comprises a tourniquet body, styptic cotton, a tightening unit, a control unit, a timer, sensors and an energy supplying unit, the tourniquet body is used for wrapping a wounded part of a user, the styptic cotton is used for stoppingbleeding of the wounded part of the user, the tightening unit is used for applying pressure on the styptic cotton to stop bleeding or relieving the pressure applied on the styptic cotton, the sensorsare used for acquiring data in a bleeding stopping process, and the control unit is used for controlling actions of the tightening unit according to the data acquired by the sensors. The tourniquet has the advantages that pressing strength and pressing time can be quantized, bleeding stopping time in the bleeding stopping process can be guaranteed effectively, a bleeding stopping effect can be affirmed in the bleeding stopping process, operations of medical workers is facilitated, medical efficiency can be increased effectively, and the circumstance of flooding or long-time blood stopping canbe avoided.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV
Method for preparing absorbable haemostatic composition for body and haemostatic composition prepared thereby
ActiveUS11357883B1Accelerate hemostasis speedRapid hemostasisSurgical adhesivesPharmaceutical delivery mechanismSurgical operationTissue repair
The present disclosure relates to a method for preparing an absorbable haemostatic composition for the body and the haemostatic composition prepared thereby, and the present disclosure is for providing a method for preparing an absorbable haemostatic composition for the body and the haemostatic composition prepared thereby, wherein the haemostatic composition can be used directly on the wound site when bleeding occurs in the surgical area such as surgical operation, trauma, etc. so that hemostasis can be effectively performed, the haemostatic composition can perform wound sealing, tissue repairing promotion, wound surface tissue protection, infection prevention, etc., the haemostatic composition is contained in haemostatic products such as gauze (cotton yarn), sponge, etc. to accelerate the hemostasis speed of the bleeding site and enable rapid hemostasis to be able to shorten the hemostasis time at the same time.
Owner:MANTIZ LOGITECH CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com